Sara Pai
0000-0002-6341-9971
Massachusetts General Hospital
4 papers found
Refreshing results…
Assessing PD-L1 Expression in Head and Neck Squamous Cell Carcinoma: Trials and Tribulations
SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
Intratumoral delivery of an HPV vaccine elicits a broad anti-tumor immune response that translates into a potent anti-tumor effect in a preclinical murine HPV model
Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040)
Missing publications? Search for publications with a matching author name.